← Leaderboards
Sarah D De Ferranti
Children'S Hospital Boston
$4,142,477
Attributed
$8,259,882
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,259,882 · 7
By mechanism
R01$3,254,257 · 1
T32$2,988,696 · 1
UM1$995,626 · 1
K23$777,497 · 1
M01$243,806 · 3
Top collaborators
- Jane W. Newburger7 shared
- William T Pu5 shared
- Andrew Edward Moran4 shared
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- David S Ludwig$17,408,359
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodChildAdultClinical TrialsAffectAtherosclerosisSerumCardiologyPreventivePhenotypeResearch PersonnelPrevalenceCardiovascular Disorder RiskLife StyleDesignProtocols DocumentationResearch MethodologyCardiovascular SystemCardiovascular Risk FactorPediatricsInflammatoryImproved OutcomeCohort StudiesBig Data
Grant awards (19)
Research Methods in Pediatric Cardiovascular Disease$548,814
T32 · FY2025 · HL
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$497,813
UM1 · FY2025 · HL · contact PI
Research Methods in Pediatric Cardiovascular Disease$575,656
T32 · FY2024 · HL
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$497,813
UM1 · FY2024 · HL · contact PI
Research Methods in Pediatric Cardiovascular Disease$703,838
T32 · FY2023 · HL
Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches$766,330
R01 · FY2022 · HL
Research Methods in Pediatric Cardiovascular Disease$505,636
T32 · FY2022 · HL
Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches$788,885
R01 · FY2021 · HL
Research Methods in Pediatric Cardiovascular Disease$654,752
T32 · FY2021 · HL
Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches$804,498
R01 · FY2020 · HL
Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches$894,544
R01 · FY2019 · HL
Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors$140,364
K23 · FY2011 · HL · contact PI
Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors$159,300
K23 · FY2010 · HL · contact PI
Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors$159,233
K23 · FY2009 · HL · contact PI
Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors$159,300
K23 · FY2008 · HL · contact PI
Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors$159,300
K23 · FY2007 · HL · contact PI
INFLAMMATORY PROFILES OF CHILDREN AT HIGH RISK FOR ATHEROSCLEROSIS$62,233
M01 · FY2007 · RR · contact PI
INFLAMMATORY PROFILES OF CHILDREN AT HIGH RISK FOR ATHEROSCLEROSIS$132,187
M01 · FY2006 · RR · contact PI
INFLAMMATORY PROFILES OF CHILDREN AT HIGH RISK FOR ATHEROSCLEROSIS$49,386
M01 · FY2005 · RR